NCT00005645 2018-09-18
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
Sanofi
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT02429726 2015-04-29
Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion
Shenzhen SiBiono GeneTech Co.,Ltd
Phase 2 Unknown
NCT01327235 2014-08-01
Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT00343291 2011-06-07
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
Eli Lilly and Company
Phase 2 Completed